BetterLife Pharma Inc. (BETRF)

OTCMKTS · Delayed Price · Currency is USD

0.2300

-0.0700 (-23.33%)

Aug 10, 2026, 3:12 PM EST

BetterLife Pharma Financials Overview

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Gross Profit	-	-	-	-	-	-
Operating Income	-1.9	-1.81	-4.72	-3.21	-9.26	-9.97
Net Income	-1.89	-1.5	-3.52	-2.89	-9.02	-12.16
Earnings Per Share	-0.01	-0.01	-0.03	-0.03	-0.10	-0.16
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Cash & Investments	0.03	0.01	0.01	0.04	0.01	0.17
Total Debt	0.96	0.9	1.33	0.56	0.19	0.31
Net Cash (Debt)	-0.93	-0.89	-1.32	-0.52	-0.18	-0.14
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.01	-0.01	-0.01	-0.00	-0.00	-0.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Operating Cash Flow	-0.85	-0.63	-2.02	-2.47	-1.5	-11.2
Capital Expenditures	-	-	-	-	-	-
Free Cash Flow	-0.85	-0.63	-2.02	-2.47	-1.5	-11.2
Free Cash Flow Growth	-	-	-	-	-	-